Anti-TMPRSS2 Nanobody (VHH), Recombinant, Purified

Anti-TMPRSS2 Nanobody (VHH), Recombinant, Purified

Catalog #: EG-NB-TMPRSS201
$425.00
View Cart
3D Structure — Nanobody–Epitope Complex
Loading 3D structure…
anti-TMPRSS2 protease nanobody complex
PDB 8S0N
nanobody (VHH)   antigen   epitope (45)
Drag to rotate · scroll to zoom

Interactive model of the VHH bound to its structural epitope on TMPRSS2 protease (from experimental complex PDB 8S0N). Nanobody in blue, epitope contact residues in red. For research visualization.

Product Description
Product NameAnti-TMPRSS2 Nanobody (VHH), Recombinant, Purified
DescriptionA purified, engineered VHH nanobody against human TMPRSS2, a viral-entry protease and prostate-cancer marker.
Target / SpecificityHuman transmembrane protease serine 2 (TMPRSS2)
SequenceThis nanobody is an engineered variant based on PDB 8S0N, with higher affinity and stability than the original published sequence.
FormatPurified recombinant single-domain antibody (VHH / nanobody), carrier-free
Tag & ExpressionC-terminal 6×His tag; secreted from HEK293 cells and purified by one-step IMAC from the culture medium.
Molecular Weight~14 kDa (single VHH domain + His6; ~1/10 the size of a conventional IgG)
Purity>90% by SDS-PAGE
Quantity100 µg
FormulationPBS with 50% glycerol (carrier-free); 0.02% sodium azide
ApplicationsELISA, IF, flow cytometry, protease-inhibition, viral-entry and prostate-cancer research
Structural EpitopeEpitope mapped from the experimental VHH–antigen complex (PDB 8S0N); 45 antigen contact residues within 5 Å. An interactive 3D complex model is shown on this page.
StorageStore at -20°C; avoid repeated freeze-thaw. Stable 1 year.
AdvantagesNanobodies are the smallest functional antibody fragments: exceptional thermal and chemical stability, single-domain, high-yield recombinant production, and access to cryptic epitopes and dense tissue that conventional antibodies cannot reach.
Product Documents
DatasheetEG-NB-TMPRSS201 Product Datasheet
Download PDF
Related Products